Welcome to our dedicated page for Sunlink Hlth SEC filings (Ticker: SSY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings archive for SunLink Health Systems, Inc. (SSY) provides a detailed regulatory record of the company’s operations, strategic shift, and eventual merger into Regional Health Properties, Inc. Investors can use these documents to understand how SunLink described its pharmacy and healthcare businesses, managed asset sales, and structured the transaction that ended SSY’s life as a standalone public company.
Key filings include multiple Forms 8-K that outline material events. An 8-K dated June 23, 2025 describes the amendment to the Amended and Restated Agreement and Plan of Merger between SunLink and Regional, extending the merger termination date. Subsequent 8-K and 8-K/A filings in July 2025 furnish press releases about proxy voting for the merger, updates on a special cash dividend, and the mechanics of due bill procedures for that dividend. An 8-K dated July 29, 2025 reports on the adjournment and reconvening of SunLink’s special meeting of shareholders to vote on the merger proposals.
The Form 8-K filed on August 14, 2025 is central to understanding the transaction. It explains that SunLink completed its merger with and into Regional on that date, with Regional surviving as the continuing corporation. The filing details the share conversion terms, including how each five shares of SunLink common stock were converted into rights to receive Regional common stock and Regional Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, with cash in lieu of fractional shares. It also notes that SunLink shareholders ceased to have rights as SunLink shareholders other than receiving the merger consideration and that a change in control occurred.
Trading and reporting status changes are documented in subsequent filings. A Form 25 filed by NYSE American on August 15, 2025 notifies the SEC of the removal of SunLink’s common stock from listing and registration on NYSE American. A Form 15 filed on August 26, 2025 certifies the termination of registration of SunLink’s common stock under Section 12(g) of the Exchange Act and the suspension of its reporting obligations under Sections 13 and 15(d), citing the completion of the merger with Regional.
Alongside these event-driven reports, SunLink’s periodic filings (such as Forms 10-K and 10-Q, referenced in its news releases) provide historical financial statements and segment information, including the prominence of pharmacy net revenues and the impact of discontinued operations related to hospital and senior care asset sales. On this page, AI-powered tools can help summarize complex filings, highlight the portions that describe the merger terms, delisting steps, and deregistration, and guide users to the specific sections that address share exchange ratios, special cash dividends, and conditions to closing.
Together, these filings form a comprehensive regulatory history of SSY, from its role as a Southeast-focused healthcare and pharmacy company to its integration into Regional Health Properties, Inc. and the subsequent delisting and deregistration of its common stock.
SunLink Health Systems, Inc. completed its previously announced merger with Regional Health Properties, Inc. effective August 14, 2025, with SunLink merging into Regional and Regional continuing as the surviving corporation. At the effective time, each five shares of SunLink common stock were converted into the right to receive 1.1330 shares of Regional common stock and one share of Regional Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, with cash paid in lieu of fractional shares. The total consideration was approximately 1,595,400 Regional common shares and approximately 1,408,120 Regional Series D preferred shares.
SunLink common shareholders ceased to have any rights as SunLink shareholders other than to receive this merger consideration. SunLink notified NYSE American that the merger would be effective at 5:00 p.m. Eastern Time on August 14, 2025, and NYSE American is expected to file Form 25 to remove SunLink common stock from listing and registration, followed by a Form 15 to deregister the shares and suspend reporting obligations. At the effective time, a change in control occurred, SunLink’s directors and key officers resigned, and former President and CEO Robert M. Thornton, Jr. waived all rights to compensation, severance, and change in control benefits under his employment agreement.
The Radoff Family Foundation and Bradley L. Radoff disclosed their holdings in SunLink Health Systems (SSY). The Foundation directly owns 345,000 shares (about 4.9% of the outstanding common stock) and Mr. Radoff directly owns 344,300 shares. Combined, Mr. Radoff may be deemed to beneficially own 689,300 shares, or roughly 9.8% of the company, based on the issuer's reported outstanding share count of 7,040,603 shares.
The filing details voting and dispositive authority: sole voting/dispositive power over 344,300 shares and shared voting/dispositive power over 345,000 shares (via the Foundation). The reporting persons state the securities are not held to change or influence control of the issuer and disclaim beneficial ownership of securities they do not directly own.
SunLink Health Systems (NYSE American: SSY) filed an amended Form 8-K to update investors on two items tied to its pending merger with Regional Health Properties.
- $0.10 special cash dividend: Board declared the dividend for holders of record 29 Jul 2025, payable 30 Jul 2025. Trades from 29-30 Jul will carry due-bills. Aggregate dividends allowed under the merger pact are capped at $1.0 million.
- Merger status: The Amended & Restated Merger Agreement (original 14 Apr 2025) was further amended 22 Jun 2025 to extend the termination date to 11 Aug 2025 and make minor clarifications. SunLink will merge into Regional, which will be the surviving entity.
The Board may revoke or postpone the dividend if (a) SunLink shareholders fail to approve the merger at the 29 Jul 2025 special meeting, (b) the agreement is terminated, amended or further extended, or (c) other conditions arise. Closing remains subject to customary conditions including both shareholder votes, effectiveness of Regional’s Form S-4 (declared effective 25 Jun 2025), and listing approvals for Regional stock.
No financial results were reported; this filing is strictly an update on corporate actions related to the merger and dividend.
SunLink Health Systems, Inc. (SSY) filed a Form 8-K to disclose an Amendment to the Amended & Restated Agreement and Plan of Merger with Regional Health Properties, Inc. The amendment, signed 22 June 2025, extends the Merger Agreement’s “Termination Date” from 30 June 2025 to 11 August 2025 (5:00 p.m. ET) and makes a minor clean-up revision.
The extension was needed because neither SunLink nor Regional has yet received their respective shareholder approvals. Both boards determined that the approvals could not be obtained by the original deadline and therefore agreed to push back the outside date. All other material terms of the Merger Agreement remain unchanged. Either party may still terminate the deal if the merger is not consummated by the new deadline.
No financial statements, earnings metrics, or revised merger economics were included in this filing. Exhibit 2.1 contains the full text of the amendment, and an Inline XBRL cover page (Exhibit 104) was provided.
- The filing reiterates that the joint proxy statement/prospectus will be filed on Form S-4 and urges investors to read it once available.
- The company restates customary “no offer or solicitation” language and an extensive list of forward-looking risk factors.
Investor takeaway: The merger remains pending but now faces at least a six-week delay, highlighting continued execution risk tied to securing shareholder and regulatory approvals.